ClinicalTrials.Veeva

Menu

haMSter: a Novel Smartphone Communication Tool for People With MS

Medical University of Vienna logo

Medical University of Vienna

Status

Completed

Conditions

Multiple Sclerosis
M-health

Treatments

Device: haMSter smartphone app

Study type

Interventional

Funder types

Other

Identifiers

NCT04555863
1798/2019

Details and patient eligibility

About

haMSter is a smartphone app that tracks validated patient reported outcome measures (PROMs) in people multiple sclerosis (MS). In this study, 50 patients with MS will receive this app for 6 months and be asked to fill out the PRO questionnaires on their Smartphone.

Endpoints include the adherence to this app and satisfaction with this Intervention.

Enrollment

50 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Any MS according to MacDonald criteria
  • informed consent

Exclusion criteria

  • language barriers

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

haMSter app
Experimental group
Description:
Patients receiving the app for personal use for 6 months
Treatment:
Device: haMSter smartphone app

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems